|
|
|
|
| RLN641a | 肺腺癌组织芯片，附病理分级、TNM和临床分期，64例/64点，替代LC641 | | 点 数 | 64 | 例 数 | 64 | | 行 数 | 8 | 列 数 | 8 | | 点直径(mm) | 1.5 | 厚度(µm) | 5.0 | | 组织阵列类型 | 石蜡包埋 | 种 属 | 人类 | | QA/QC | H&E and IHC confirmed | | Applications | Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page. | | Notes | 1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better. 2.Bake the slides for 30 minutes at 60℃ before the experiment; 3.Please choose a gentle repair method to avoid tissue detachment. |
|
|
| |
|
Legend:
|
|
Malignant (IA) Malignant (IB) Malignant (IIA) Malignant (IIB) Malignant (IIIA) Malignant (IIIB) |
|
|
|
| |
| Pos | No | Age | Sex | Organ_Anatomic_Site | Pathology_diagnosis | Grade | TNM | Stage | Type | isBackUp |
| A1 | 1 | 56 | F | Lung | Acinar adenocarcinoma | 1--2 | T2bN0M0 | IIA | Malignant | N |
| A2 | 2 | 48 | M | Lung | Acinar adenocarcinoma | 2 | T2aN0M0 | IB | Malignant | N |
| A3 | 3 | 54 | F | Lung | Acinar adenocarcinoma | 2 | T2aN0M0 | IB | Malignant | N |
| A4 | 4 | 59 | F | Lung | Acinar adenocarcinoma | 2 | T2aN0M0 | IB | Malignant | N |
| A5 | 5 | 56 | M | Lung | Acinar adenocarcinoma | 2 | T2aN2M0 | IIIA | Malignant | N |
| A6 | 6 | 58 | F | Lung | Acinar adenocarcinoma | 2 | T3N0M0 | IIB | Malignant | N |
| A7 | 7 | 49 | M | Lung | Acinar adenocarcinoma | 2 | T2bN0M0 | IIA | Malignant | N |
| A8 | 8 | 49 | M | Lung | Acinar adenocarcinoma | 2 | T2aN0M0 | IB | Malignant | N |
| B1 | 9 | 58 | F | Lung | Acinar adenocarcinoma | 2 | T2bN1M0 | IIB | Malignant | N |
| B2 | 10 | 62 | M | Lung | Acinar adenocarcinoma | 2 | T3N0M0 | IIB | Malignant | N |
| B3 | 11 | 61 | F | Lung | Acinar adenocarcinoma | 2--3 | T3N0M0 | IIB | Malignant | N |
| B4 | 12 | 38 | M | Lung | Acinar adenocarcinoma | 2 | T4N2M0 | IIIB | Malignant | N |
| B5 | 13 | 38 | M | Lung | Acinar adenocarcinoma | 2--3 | T3N0M0 | IIB | Malignant | N |
| B6 | 14 | 69 | F | Lung | Acinar adenocarcinoma | 2--3 | T2aN0M0 | IB | Malignant | N |
| B7 | 15 | 39 | M | Lung | Acinar adenocarcinoma | 2--3 | T2aN0M0 | IB | Malignant | N |
| B8 | 16 | 50 | M | Lung | Acinar adenocarcinoma | 2--3 | T2aN0M0 | IB | Malignant | N |
| C1 | 17 | 46 | F | Lung | Acinar adenocarcinoma | 2--3 | T1aN0M0 | IA | Malignant | N |
| C2 | 18 | 60 | M | Lung | Acinar adenocarcinoma | 2--3 | T2bN0M0 | IIA | Malignant | N |
| C3 | 19 | 54 | F | Lung | Acinar adenocarcinoma | 2--3 | T4N1M0 | IIIB | Malignant | N |
| C4 | 20 | 48 | M | Lung | Acinar adenocarcinoma | 3 | T2aN0M0 | IB | Malignant | N |
| C5 | 21 | 73 | M | Lung | Acinar adenocarcinoma | 3 | T2bN1M0 | IIB | Malignant | N |
| C6 | 22 | 39 | M | Lung | Acinar adenocarcinoma | 3 | T3N0M0 | IIB | Malignant | N |
| C7 | 23 | 40 | M | Lung | Acinar adenocarcinoma | 3 | T2aN0M0 | IB | Malignant | N |
| C8 | 24 | 40 | M | Lung | Acinar adenocarcinoma | 3 | T2aN0M0 | IB | Malignant | N |
| D1 | 25 | 51 | M | Lung | Acinar adenocarcinoma | 3 | T2aN0M0 | IB | Malignant | N |
| D2 | 26 | 45 | F | Lung | Acinar adenocarcinoma | 3 | T2bN0M0 | IIA | Malignant | N |
| D3 | 27 | 74 | M | Lung | Acinar adenocarcinoma | 3 | T2N0M0 | IB | Malignant | N |
| D4 | 28 | 59 | M | Lung | Acinar adenocarcinoma | 3 | T2N0M0 | IB | Malignant | N |
| D5 | 29 | 45 | M | Lung | Papillary adenocarcinoma | 1 | T2aN0M0 | IB | Malignant | N |
| D6 | 30 | 64 | F | Lung | Papillary adenocarcinoma | 1 | T2aN0M0 | IB | Malignant | N |
| D7 | 31 | 51 | F | Lung | Papillary adenocarcinoma | 1--2 | T2aN0M0 | IB | Malignant | N |
| D8 | 32 | 47 | F | Lung | Papillary adenocarcinoma | 2 | T3N1M0 | IIIA | Malignant | N |
| E1 | 33 | 56 | F | Lung | Papillary adenocarcinoma | 2 | T2bN1M0 | IIB | Malignant | N |
| E2 | 34 | 60 | M | Lung | Papillary adenocarcinoma | 2 | T2aN0M0 | IB | Malignant | N |
| E3 | 35 | 60 | F | Lung | Papillary adenocarcinoma | 2 | T2aN0M0 | IB | Malignant | N |
| E4 | 36 | 58 | M | Lung | Papillary adenocarcinoma | 2 | T2bN0M0 | IIA | Malignant | N |
| E5 | 37 | 61 | F | Lung | Papillary adenocarcinoma | 2 | T2aN1M0 | IIA | Malignant | N |
| E6 | 38 | 60 | F | Lung | Papillary adenocarcinoma | 2 | T2aN0M0 | IB | Malignant | N |
| E7 | 39 | 49 | F | Lung | Papillary adenocarcinoma | 2 | T2aN0M0 | IB | Malignant | N |
| E8 | 40 | 59 | F | Lung | Papillary adenocarcinoma | 2 | T2aN1M0 | IIA | Malignant | N |
| F1 | 41 | 44 | F | Lung | Papillary adenocarcinoma | 2 | T2bN0M0 | IIA | Malignant | N |
| F2 | 42 | 49 | M | Lung | Papillary adenocarcinoma | 2 | T2aN0M0 | IB | Malignant | N |
| F3 | 43 | 82 | M | Lung | Papillary adenocarcinoma | 2--3 | T4N1M0 | IIIA | Malignant | N |
| F4 | 44 | 46 | F | Lung | Papillary adenocarcinoma | 2--3 | T2bN0M0 | IIA | Malignant | N |
| F5 | 45 | 42 | M | Lung | Micropapillary adenocarcinoma | 2--3 | T2aN0M0 | IB | Malignant | N |
| F6 | 46 | 51 | M | Lung | Papillary adenocarcinoma | 3 | T2aN0M0 | IB | Malignant | N |
| F7 | 47 | 36 | M | Lung | Invasive mucinous adenocarcinoma | 2 | T2bN0M0 | IIA | Malignant | N |
| F8 | 48 | 64 | F | Lung | Invasive adenocarcinoma | 2--3 | T2aN0M0 | IB | Malignant | N |
| G1 | 49 | 52 | M | Lung | Invasive adenocarcinoma | 3 | T3N0M0 | IIB | Malignant | N |
| G2 | 50 | 44 | M | Lung | Invasive adenocarcinoma | 3 | T2aN0M0 | IB | Malignant | N |
| G3 | 51 | 60 | M | Lung | Invasive adenocarcinoma | 3 | T2bN0M0 | IIA | Malignant | N |
| G4 | 52 | 65 | M | Lung | Solid adenocarcinoma | 3 | T3N0M0 | IIB | Malignant | N |
| G5 | 53 | 59 | M | Lung | Solid adenocarcinoma | 3 | T2aN0M0 | IB | Malignant | N |
| G6 | 54 | 67 | M | Lung | Solid adenocarcinoma | 3 | T2bN0M0 | IIA | Malignant | N |
| G7 | 55 | 46 | M | Lung | Solid adenocarcinoma | 3 | T2bN0M0 | IIA | Malignant | N |
| G8 | 56 | 62 | M | Lung | Solid adenocarcinoma | 3 | T2aN0M0 | IB | Malignant | N |
| H1 | 57 | 67 | M | Lung | Solid adenocarcinoma | 3 | T1aN0M0 | IA | Malignant | N |
| H2 | 58 | 66 | M | Lung | Solid adenocarcinoma | 3 | T2bN0M0 | IIA | Malignant | N |
| H3 | 59 | 56 | M | Lung | Solid adenocarcinoma | 3 | T3N1M0 | IIIA | Malignant | N |
| H4 | 60 | 51 | M | Lung | Solid adenocarcinoma | 3 | T3N0M0 | IIB | Malignant | N |
| H5 | 61 | 62 | M | Lung | Solid adenocarcinoma | 3 | T2aN0M0 | IB | Malignant | N |
| H6 | 62 | 66 | M | Lung | Solid adenocarcinoma | 3 | T2aN0M0 | IB | Malignant | N |
| H7 | 63 | 70 | M | Lung | Solid adenocarcinoma | 3 | T2bN0M0 | IIA | Malignant | N |
| H8 | 64 | 62 | M | Lung | Solid adenocarcinoma | 3 | T2aN0M0 | IB | Malignant | N | | Tissue Marker |
|
|
